Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
Science & Environment
The Latest
A New Phase
The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
Four UC San Diego Scientists Elected AAAS Fellows
Four UC San Diego researchers have been elected 2022 AAAS Fellows. Stuart Brody, Massimiliano Di Ventra, Elizabeth Komives and Yunde Zhao are being recognized for their scientifically and socially distinguished achievements by AAAS, publisher of the journal Science.
Therapeutic Potential of Bizarre ‘Jumbo’ Viruses Tapped for $10M HHMI Emerging Pathogens Project
UC San Diego and its collaborating partners have been awarded $10 million from the Howard Hughes Medical Institute to leverage the biomedical promise of viruses known as bacteriophages as new therapeutic agents in the fight against the rising crisis of antibiotic-resistant bacterial infections.
Computer Model of Influenza Virus Shows Universal Vaccine Promise
For the first time, researchers at UC San Diego have created an atomic-level computer model of the H1N1 virus that reveals new vulnerabilities, suggesting possible strategies for the design of future vaccines and antivirals against influenza.
More Steps, Moderate Physical Activity Cuts Dementia, Cognitive Impairment Risk
UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science study: senior women were less likely to develop mild cognitive impairment or dementia if they did more daily walking and moderate-to-vigorous physical activity.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
